MUSSETTI, ALBERTO

MUSSETTI, ALBERTO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation 1-mar-2013 F. SpinaA. MussettiP. Corradini + Article (author) -
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide 1-dic-2018 Mussetti, A.de Philippis, C.Carniti, C.Cieri, N.Pennisi, M.Ciceri, F.Mariotti, J.Castagna, L.Corradini, P. + Article (author) -
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era 1-gen-2022 Mussetti, AlbertoDerenzini, Enrico + Article (author) -
Handling the COVID-19 pandemic in the oncological setting 7-mag-2020 Mussetti A.Corradini P. + Article (author) -
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis 1-set-2017 L. CastagnaA. MussettiF. MauraC. de PhilippisP. Corradini + Article (author) -
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles 1-gen-2017 N. BolliM. BarcellaE. SalviF. D'AvilaA. VendraminC. De PhilippisA. MussettiF. MauraC. BarlassinaP. Corradini + Article (author) -
Ocular disorders in multiple myeloma patients: cross-sectional study of prevalence and association with treatment 1-lug-2018 Pennisi, MartinaMussetti, AlbertoCACIOPPO, VIVIANADAVID, ALESSANDROCorradini, Paolo + Article (author) -
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis : where do we stand? 1-mag-2017 A. MussettiGRECO, RAFFAELLAP. Corradini + Article (author) -
Recurrent Hodgkin lymphoma : toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents 1-lug-2015 P. CorradiniA. Mussetti + Article (author) -
Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors 1-gen-2018 P. CorradiniA. Mussetti + Article (author) -